Amber Yates: Honoring the Sickle Cell Community Behind the Rise Up Study
Amber Yates, Senior Medical Director and Global Medical Affairs Leader at Agios Pharmaceuticals, shared a post on LinkedIn:
“Reflecting on Day 3 at EHA 2026.
Today, we shared the RISE UP results from Agios.
Five years ago, I made the decision to step away from academic medicine.
It wasn’t easy, because caring directly for patients with Sickle Cell shaped so much of who I was as a physician.
But I left with a very clear purpose: to find a way to impact more lives, at a broader scale, than I could one patient at a time.
Sitting with my colleagues today and seeing these data being shared with the hematology community, fills me with pride for the Sickle Cell community—patients and families who showed up, trusted the process, and participated in RISE UP—this progress is only possible through their courage and commitment.
Grateful to be part of a community that continues to show up and keep patients at the center of everything we do.
A thousand thanks to Ahmar U. Zaidi, who is the shining light of encouragement at Agios.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?